Amel Mettouchi

2.8k citations
39 papers · 2.0k indexed · h-index 22
Topics
Cell Adhesion Molecules Research (11 papers)Ubiquitin and proteasome pathways (6 papers)Angiogenesis and VEGF in Cancer (6 papers)

In The Last Decade

Amel Mettouchi

39 papers receiving 2.0k citations

Peers

Amel Mettouchi
Comparison fields: 5 of 104
  • Molecular Biology 1.4k
  • Cell Biology 461
  • Oncology 307
  • Immunology and Allergy 281
  • Plant Science 271
Replace Tevie Mehlman with:
Tevie Mehlman Israel
Violaine Moreau France
Markus Zettl United Kingdom
Stefan Vermeulen Belgium
Jørgen Wesche Norway
Mataleena Parikka Finland
Tzuu‐Shuh Jou Taiwan
Peter Schu Germany
Santiago Cal Spain
Lynda M. Pierini United States
Amel Mettouchi relative to Tevie Mehlman Israel Tevie Mehlman's profile →
Citations per field
00.5×5.8×
Tevie Mehlman · 1×
Citations per year

Countries citing papers authored by Amel Mettouchi

Since Specialization
Citations

This map shows the geographic impact of Amel Mettouchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amel Mettouchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amel Mettouchi more than expected).

Fields of papers citing papers by Amel Mettouchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amel Mettouchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amel Mettouchi. The network helps show where Amel Mettouchi may publish in the future.

Co-authorship network of co-authors of Amel Mettouchi

This figure shows the co-authorship network connecting the top 25 collaborators of Amel Mettouchi. A scholar is included among the top collaborators of Amel Mettouchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amel Mettouchi. Amel Mettouchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 14
3 3
4 17
5 18
6 17
7 34
8 23
9 28
10 21
11 127
12 40
13 6
14 112
15 23
16 69
17 38
18 1
19 54
20 64

About Amel Mettouchi

Amel Mettouchi is a scholar working on Immunology and Allergy, Cell Biology and Endocrinology, having authored 39 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (11 papers), Ubiquitin and proteasome pathways (6 papers) and Angiogenesis and VEGF in Cancer (6 papers). The work is most often cited by research in Immunology and Allergy (281 citations), Cell Biology (461 citations) and Endocrinology (106 citations). Amel Mettouchi has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Emmanuel Lemichez, Anne Doye, Bernard Binétruy, G Laurent, Guerrino Meneguzzi, Miguel A. López-Lago, Filippo G. Giancotti, John Westwick, Wenjun Guo and Sharon Klein. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026